Understanding the role of various cytokines has opened new therapeutic possibilities. TNF-α inhibition shows promise in reducing inflammation, IL-11 pathway modulation may help reverse liver fibrosis, and TGF-β targeting could reduce fibrosis progression [3]. Here, TGFB1 is linked to Hepatic fibrosis.